Cell Arrays Generated by a Novel Transfection Method

Information

  • Research Project
  • 6644695
  • ApplicationId
    6644695
  • Core Project Number
    R43CA101443
  • Full Project Number
    1R43CA101443-01
  • Serial Number
    101443
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/2003 - 21 years ago
  • Project End Date
    3/31/2004 - 20 years ago
  • Program Officer Name
    ARYA, SURESH
  • Budget Start Date
    4/1/2003 - 21 years ago
  • Budget End Date
    3/31/2004 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    -

Cell Arrays Generated by a Novel Transfection Method

[unreadable] DESCRIPTION (provided by applicant): To address the rising need for cell assays in drug discovery, we propose a method for the rapid and simple generation of cell arrays by incorporating a novel transfection method into our current cell array technology. Our technology platform uses encoded microcarriers to multiplex pre-established cell types for simultaneous interrogation in a single microtiter well. We propose to combine our platform with a method of "reverse transfection" in which cells become transfected with material pre-deposited on a substrate. Specifically, we propose to use the carriers to deliver transfection material to cells plated on top of them. This approach would enable drug discovery laboratories to perform cell assays in a multiplexed manner, thereby decreasing the time, labor and reagent use involved with these assays as well as increasing the quality of data obtained from them. In addition, using reverse transfection to generate cell arrays substantially decreases the tissue culture burden associated with traditional transfection by alleviating the need for separate transfections and stable cell lines. We have obtained preliminary data supporting the technical feasibility of reverse transfection using encoded carriers. In this proposal, we outline a strategy for optimizing this approach and testing its feasibility for use in multiplexed cell assays. [unreadable] [unreadable]

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    VITRA BIOSCIENCE, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    MOUNTAIN VIEW
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94043
  • Organization District
    UNITED STATES